In patients with squamous cervical cancer, APOA1 overexpression can reduce the sensitivity of cervical squamous cells to carboplatin by regulating the expression of STAT1, CD81, C3, and TOP2A [19]. This evidence concerns the gene CD81 and cervical squamous cell carcinoma.